secwatch / observer
8-K filed June 12, 2023, 7:59 PM ET ticker SGHT CIK 0001531177
other confidence high sentiment neutral materiality 0.15

Sight Sciences annual meeting elects directors, ratifies auditor

Sight Sciences, Inc.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sight Sciences, Inc. shareholders approved Election of two Class II directors to serve until the Company's annual meeting of stockholders to be held in 2026 at the 2023-06-08 meeting.

Proposal
director election
Outcome
passed
Meeting
2023-06-08
Exact text from the filing
Item 1 – Election of two Class II directors to serve until the Company’s annual meeting of stockholders to be held in 2026 and until each such director’s respective successor has been duly elected and qualified or until each such director’s earlier death, resignation or removal. Votes FOR Votes WITHHELD Broker Non-Votes Staffan Encranz 25,200,595 10,308,666 6,200,625 Catherine Mazzacco 35,458,052 51,209 6,200,625
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Sight Sciences, Inc. shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2023 at the 2023-06-08 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2023-06-08
Exact text from the filing
Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. Votes FOR Votes AGAINST Votes ABSTAINED Broker Non-Votes 41,688,515 4,435 16,936 0
View on SEC.gov

545 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Sight Sciences, Inc. filing history →

Source: SEC EDGAR
accession 0000950170-23-027489
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.